Form 4: ALX Oncology SVP, Finance and CAO, Shelly Pinto, Sells Shares to Cover Tax Obligations

Shelly Pinto, SVP, Finance and CAO of ALX Oncology Holdings Inc., sold 1,373 shares of common stock on July 1, 2024, to satisfy tax obligations related to vesting restricted stock units.

Summary

• On July 1, 2024, Shelly Pinto, the SVP, Finance and CAO of ALX Oncology Holdings Inc., sold 1,373 shares of common stock.
• The sale was executed at a weighted average price of $5.8188 per share, with individual transactions ranging from $5.77 to $5.82.
• The purpose of the sale was to cover tax obligations associated with the vesting of restricted stock units.
• Following the transaction, Pinto directly owns 93,936 shares of ALX Oncology Holdings Inc.
• This total includes 1,718 shares acquired through the company's employee stock purchase plan on June 28, 2024.

Sentiment

Score: 5

Explanation: This is a neutral event. An executive selling shares to cover tax obligations is a routine transaction and doesn't necessarily indicate a positive or negative outlook on the company.

Industry Context

This is a routine Form 4 filing, indicating insider transactions. It's common for executives to sell shares to cover tax obligations related to vesting equity.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders and are publicly available.
• The sale of shares to cover tax obligations is a common financial planning strategy among executives.
• Comparable companies such as Gilead, Amgen, and Biogen also have executives who regularly file Form 4s.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the context.

Key Dates